Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 9(2): e88846, 2014.
Article in English | MEDLINE | ID: mdl-24586411

ABSTRACT

BACKGROUND: CpG oligodeoxynucleotides (ODNs), resembling bacterial DNA, are currently tested in clinical trials as vaccine adjuvants. They have the nuclease-resistant phosphorothioate bond; the immune responses elicited differ according to the CpG ODN sequence and vaccination method. To develop a CpG ODN that can induce plasmacytoid dendritic cell (pDC)-mediated T(H)1 immunity through the mucosa, we constructed phosphodiester G9.1 comprising one palindromic CpG motif with unique polyguanosine-runs that allows degradation similar to naturally occurring bacterial DNA. METHODS: T(H)1 and T(H)2 immunity activation was evaluated by cytokine production pattern and T-bet/GATA-3 ratio in human peripheral blood mononuclear cells and mouse bone marrow cells. Adjuvanticity was evaluated in mice administered G9.1 with diphtheria toxoid (DT) through nasal vaccination. RESULTS: G9.1 exhibited stronger IFN-α-inducing activity than A-class CpG ODN2216 and increased T-bet/GATA-3 ratio by enhancing T-bet expression. Nasally administered G9.1 plus DT induced DT-specific mucosal IgA and serum IgG, but not IgE, responses with antitoxin activity in C57BL/6 and BALB/c mice, possibly due to IFN/BAFF production. Induction of T(H)1, but not T(H)2-type Abs depended completely on pDCs, the first in vivo demonstration by CpG ODNs. CONCLUSIONS: G9.1 is a promising mucosal adjuvant for induction of pDC-mediated T(H)1 immunity.


Subject(s)
Adjuvants, Immunologic/pharmacology , Adjuvants, Pharmaceutic/pharmacology , Dendritic Cells/immunology , Mucous Membrane/immunology , Oligodeoxyribonucleotides/immunology , Th1 Cells/immunology , Animals , Bone Marrow Cells/drug effects , Bone Marrow Cells/immunology , DNA, Bacterial/immunology , Dendritic Cells/drug effects , Diphtheria Toxoid/immunology , Female , Humans , Interferon-alpha/immunology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mucous Membrane/drug effects , Th1 Cells/drug effects
2.
Acta Otolaryngol ; 131(1): 96-100, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21034170

ABSTRACT

CONCLUSIONS: We conclude that the capsaicin inhalation test is useful to directly assess cough reflex and sensation around the larynx, while it indirectly reflects central nervous system function. OBJECTIVES: To understand the state of the cough reflex before patients with dysphagia start eating. METHODS: We studied the cough reflex by the capsaicin inhalation test in 21 patients with dysphagia and 12 healthy persons without dysphagia. RESULTS: The control group showed a cough reflex at a capsaicin concentration of 2.61 µM (0.98-7.80), while patients with mild dysphagia did so at 7.28 µM (1.95-15.6), those with moderate dysphagia at 22.07 µM (15.6-62.5), and those with severe dysphagia at 71.75 µM (31.2-250). Control vs mild p < 0.01, control vs moderate p < 0.01, control vs severe p < 0.01, mild vs moderate p < 0.01, mild vs severe p < 0.01, moderate vs severe p < 0.05. There was a significant correlation between the grade of dysphagia and the threshold capsaicin concentration that provoked a cough reflex (ρ = -0.796, p < 0.001).


Subject(s)
Capsaicin , Cough/physiopathology , Reflex/physiology , Administration, Inhalation , Aged , Aged, 80 and over , Capsaicin/administration & dosage , Deglutition Disorders/physiopathology , Deglutition Disorders/rehabilitation , Dose-Response Relationship, Drug , Female , Humans , Larynx/physiopathology , Male , Middle Aged , Predictive Value of Tests , Reference Values
3.
J Immunol ; 177(7): 4841-52, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16982926

ABSTRACT

CpG DNA induces plasmacytoid dendritic cells (pDC) to produce type I IFN and chemokines. However, it has not been fully elucidated how the TLR9 signaling pathway is linked to these gene expressions. We examined the mechanisms involving the TLR9 and type I IFN signaling pathways, in relation to CpG DNA-induced IFN-alpha, IFN regulatory factor (IRF)-7, and chemokines CXCL10 and CCL3 in human pDC. In pDC, NF-kappaB subunits p65 and p50 were constitutively activated. pDC also constitutively expressed IRF-7 and CCL3, and the gene expressions seemed to be regulated by NF-kappaB. CpG DNA enhanced the NF-kappaB p65/p50 activity, which collaborated with p38 MAPK to up-regulate the expressions of IRF-7, CXCL10, and CCL3 in a manner independent of type I IFN signaling. We then examined the pathway through which IFN-alpha is expressed. Type I IFN induced the expression of IRF-7, but not of IFN-alpha, in a NF-kappaB-independent way. CpG DNA enabled the type I IFN-treated pDC to express IFN-alpha in the presence of NF-kappaB/p38 MAPK inhibitor, and chloroquine abrogated this effect. With CpG DNA, IRF-7, both constitutively and newly expressed, moved to the nuclei independently of NF-kappaB/p38 MAPK. These findings suggest that, in CpG DNA-stimulated human pDC, the induction of IRF-7, CXCL10, and CCL3 is mediated by the NF-kappaB/p38 MAPK pathway, and that IRF-7 is activated upstream of the activation of NF-kappaB/p38 MAPK in chloroquine-sensitive regulatory machinery, thereby leading to the expression of IFN-alpha.


Subject(s)
Chemokines/biosynthesis , CpG Islands/immunology , Dendritic Cells/metabolism , NF-kappa B/metabolism , Signal Transduction/immunology , p38 Mitogen-Activated Protein Kinases/metabolism , Blotting, Western , Dendritic Cells/immunology , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Gene Expression , Humans , Interferon Regulatory Factor-7/immunology , Interferon Regulatory Factor-7/metabolism , Interferon-alpha/immunology , Interferon-alpha/metabolism , NF-kappa B/immunology , Reverse Transcriptase Polymerase Chain Reaction , Toll-Like Receptor 9/immunology , Toll-Like Receptor 9/metabolism , p38 Mitogen-Activated Protein Kinases/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...